CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 46 enrolled
Drug / intervention
Oral glucose breath testother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01846767
NCT01846767N/ACompleted
CompareCT.gov

Study of the Metabolism of 13C Labelled Glucose to 13CO2 in Human Breath

National University of Ireland, Galway, Ireland·interventional·Posted May 3, 2013·Updated Nov 26, 2014

In Brief

A clinical study evaluating Oral glucose breath test for Diabetes Mellitus, Type 2. Completed, enrolled 46 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if oxidation of 13C glucose to 13CO2 is changed in type 2 diabetic patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesIreland
CollaboratorsIrish Endocrine Society

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 3, 2013
Enrollment StartApr 1, 2012
Primary CompletionDec 1, 2013
Study CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 13.2 years ago

Interventions

Oral glucose breath testother

Simultaneous oral glucose tolerance test and exogenous 13C-glucose breath test following a 12hr overnight fast. Fasting samples were obtained for plasma glucose, insulin, c-peptide, leptin, adiponectin, resistin, HbA1c and two breath 13CO2 abundance values (at t = -15 and -5min). At t = 0min, each subject drank a 75g glucose solution (Thornton \& Ross, UK) containing 0.15g of 1-13C glucose. Further breath samples (every 15 min over a 240min interval) and further plasma blood glucose, insulin and c-peptide samples (90,120,180min) were also taken.